Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls-Reference-Cited by-同舟云学术

Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls

Published:2021-08-06 Issue:9 Volume:20 Page:4303-4317
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Jasbi Paniz¹^ORCID,Shi Xiaojian¹²^ORCID,Chu Ping,Elliott Natalie,Hudson Haley,Jones Douglas,Serrano Geidy³,Chow Brandon¹,Beach Thomas G.³,Liu Li⁴⁵,Jentarra Garilyn⁶,Gu Haiwei¹^ORCID

Affiliation:

1. Arizona Metabolomics Laboratory, College of Health Solutions, Arizona State University, 850 N 5th Street, Phoenix, Arizona 85004, United States

2. Systems Biology Institute, Cellular and Molecular Physiology, Yale School of Medicine, West Haven, Connecticut 06516, United States

3. Banner Sun Health Research Institute, Sun City, Arizona 85351, United States

4. College of Health Solutions, Biodesign Institute, Arizona State University, Tempe, Arizona 85281, United States

5. Department of Neurology, Mayo Clinic, Scottsdale, Arizona 85259, United States

6. Precision Medicine Program, Midwestern University, 19555 N 59th Avenue, Glendale, Arizona 85308, United States

Funder

National Institute of Neurological Disorders and Stroke

Arizona Department of Health Services

Midwestern University

Michael J. Fox Foundation for Parkinson's Research